Rachel Westbay
Dermatology · New York, NYNPI 1598127730
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $50,023 of the $63,605 with a category attached, or 78.6%. Incyte Corporation accounts for 81.8% of it on its own, with 25 other manufacturers making up the rest. Among dermatology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 500 payments — averaging $127.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$52K
- Solta Medical, A Division Of Bausch Health US, LLC$3K
- Galderma Laboratories, L.p.$2K
- Merz North America, Inc.$1K
- Dermavant Sciences, Inc.$1K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$1K
- plus $4K from 20 others
What the payments were for
- Speaking & faculty fees$50,02379%
- Travel & lodging$9491%
- Food & beverage$12,61920%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 137 | $52,039 |
| Solta Medical, A Division Of Bausch Health US, LLC | 3 | $2,517 |
| Galderma Laboratories, L.p. | 90 | $1,881 |
| Merz North America, Inc. | 21 | $1,378 |
| Dermavant Sciences, Inc. | 56 | $1,108 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 46 | $1,019 |
| AbbVie(2 entities) | 42 | $937 |
| Johnson & Johnson | 14 | $380 |
| Lilly USA, LLC | 13 | $333 |
| Journey Medical Corporation | 11 | $312 |
| Sanofi | 11 | $296 |
| Pfizer | 14 | $294 |
| Regeneron Healthcare Solutions, Inc. | 7 | $169 |
| UCB, Inc. | 5 | $149 |
| LEO Pharma Inc. | 5 | $138 |
| E.r. Squibb & Sons, L.L.C. | 6 | $137 |
| Revance Therapeutics, Inc. | 2 | $135 |
| Botanix SB Inc | 5 | $115 |
| VYNE Pharmaceuticals Inc. | 3 | $65 |
| Almirall LLC | 3 | $58 |
| Novartis | 1 | $28 |
| Arcutis Biotherapeutics, Inc. | 1 | $26 |
| EPI Health, LLC | 1 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| Mayne Pharma Commercial LLC | 1 | $22 |
| Organon | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$63,605 in reported general payments places this provider in the 90th percentile of 1,151 dermatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dutasteride | 13 | $475 |
| NyamycNystatin | 13 | $281 |
| Clobetasol Propionate | 13 | $273 |
| ValacyclovirValacyclovir Hcl | 11 | $202 |
| Triamcinolone Acetonide | 23 | $202 |
| Minoxidil | 19 | $181 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.